April 1, 1996 -
Tim Horn -
... for Invirase, the brand name of Hoffmann-La Roche's saquinavir. But Brigette has yet to hand ... in combination with the other two drugs -- through Roche's compassionate use program, he began hitting pay ... s angst originated with the evidence, acknowledged by Roche, that saquinavir is so poorly absorbed by the ... lie ahead with other protease inhibitors. Hoffmann-La Roche prides itself on being the first company to ... activity stronger than any existing drug. In 1992, Roche launched clinical trials of saquinavir in the ...
http://www.poz.com/articles/250_1783.shtml
October 23, 2008 -
Peter Staley -
Hoffmann-La Roche, a pharmaceutical company with a checkered history in ... is sadly a growth industry. But back to Roche. They've always been one of the weakest ... biotech called Trimeris, discovered it. They partnered with Roche to help them market it. Even still, the ... to-take salvage therapies have hit the market. Roche fumbled the development and marketing of all three ... their Nutley, NJ headquarters in February, 1993, protesting Roche's refusal to offer ddC on expanded ...
http://blogs.poz.com/peter/archives/2008/07/roche_abandons.html
December 1, 2002 -
Mike Barr -
... were dialing to save lives. Swiss drug giant Roche was offering early access to its hot new ... But part of their hard luck was that Roche, which had partnered with Fuzeon's original developer ... the drug for three patients, the maximum that Roche permitted any single physician. When one of Grossman ... had clamored for (see "Do Activists Play Favorites?"). Roche insisted that the 70-something-step production process ... ironically, the best news went largely unreported, because Roche/Trimeris was skirting the "injection" issue: While ...
http://www.poz.com/articles/183_1015.shtml
June 7, 2007 -
Tim Horn -
June 7, 2007 Roche's Viracept Recalled; Pfizer's U.S. Version Okay (AIDSmeds.com) by Tim Horn Roche, the manufacturer of Viracept® (nelfinavir) in all countries ... According to a June 6 press release from Roche, the company “received several reports that some ... acid ethylester. In the interest of patients safety Roche has decided to recall all batches of Viracept ... Agency (EMEA),is advising patients in countries where Roche's Viracept is used“to contact ...
http://www.poz.com/articles/761_12002.shtml
June 7, 2007 -
Tim Horn -
June 7, 2007 Roche's Viracept Recalled; Pfizer's U.S. Version Okay (AIDSmeds.com) by Tim Horn Roche, the manufacturer of Viracept® (nelfinavir) in all countries ... According to a June 6 press release from Roche, the company “received several reports that some ... acid ethylester. In the interest of patients safety Roche has decided to recall all batches of Viracept ... Agency (EMEA),is advising patients in countries where Roche's Viracept is used“to contact ...
http://www.aidsmeds.com/articles/1667_12002.shtml
September 1, 1997 -
John Hammond -
September 1997 Roche Trap by John Hammond Hoffman-La Roche, maker of saquinavir (Invirase), stands accused of shoddy ... dose is the drug safe and effective. But Roche calls the TAG rag’s tongue-lashing so ... as the runt of the protease litter. So Roche got busy developing a soft-gel-capsule that ... TAG and Project Inform, activists nationwide demand that Roche pull the ads for its current formulation, ...
http://www.poz.com/articles/244_11922.shtml
July 10, 2008 -
July 10, 2008 Roche Abandoning In-House HIV Research Roche pharmaceuticals has alerted the community that it is ... were all in the earliest stages of development. Roche, however, says, “We now have concluded that ... the market.” In light of this setback, Roche has “decided to refocus [its] resources within ... over existing medicines,” including hepatitis C. While Roche will continue manufacturing and selling Invirase and ...
http://www.poz.com/articles/hiv_roche_invirase_761_14898.shtml
July 10, 2008 -
July 10, 2008 Roche Abandoning In-House HIV Research Roche pharmaceuticals has alerted the community that it is ... were all in the earliest stages of development. Roche, however, says, “We now have concluded that ... the market.” In light of this setback, Roche has “decided to refocus [its] resources within ... over existing medicines,” including hepatitis C. While Roche will continue manufacturing and selling Invirase and ...
http://www.aidsmeds.com/articles/hiv_roche_invirase_1667_14898.shtml
January 13, 2006 -
January 13, 2006 Roche To Pass On Med-Making Skills January 13, 2006—Pharma company Roche announced plans yesterday to offer drug manufacturers in ... of a drug company passing on such skills. Roche already has a policy of not enforcing patents ...
http://www.poz.com/articles/1_2586.shtml
January 17, 2006 -
January 17, 2006 Roche s Med Offer Under Fire January 17, 2006 ... have the manufacturing capacity to produce the drug. Roche responded to the charges by saying that it ...
http://www.poz.com/articles/1_2589.shtml
